EDITORIAL

How to Live for 300 Years: Searching for the Best Way Forward

♥ 14553 Thanks from members

Currently, no single medical protocol guarantees a 300-year lifespan. The realistic strategy is Longevity Escape Velocity: optimizing cellular resilience today to survive until next-generation interventions arrive. Explore evidence-based clinical roadmaps combining therapeutic plasma exchange, epigenetic reprogramming, and somatic organ regeneration.

To live for 300 years and witness the future in optimal health, what is the best roadmap? Here, clinicians, researchers, and network members debate how to combine emerging clinical protocols, navigate biological bottlenecks, and realistically map out an actionable survival strategy.

Member Opinions and Insights

Member@user_770183

Endothelial glycocalyx degradation precedes clinical vascular stiffness by decades. Need better non-invasive diagnostic tracking protocols.

♥ 13 Thanks

Member@user_318448

Albumin replacement ratios in TPE need careful calibration; 5% solution seems to deplete ferritin too aggressively in bi-weekly protocols.

♥ 36 Thanks

Member@user_896466

Endothelial glycocalyx degradation precedes clinical vascular stiffness by decades. Need better non-invasive diagnostic tracking protocols.

♥ 21 Thanks

Member@user_224498

Endothelial glycocalyx degradation precedes clinical vascular stiffness by decades. Need better non-invasive diagnostic tracking protocols.

♥ 39 Thanks

Member@user_775609

Albumin replacement ratios in TPE need careful calibration; 5% solution seems to deplete ferritin too aggressively in bi-weekly protocols.

♥ 38 Thanks

Member@user_337024

Albumin replacement ratios in TPE need careful calibration; 5% solution seems to deplete ferritin too aggressively in bi-weekly protocols.

♥ 18 Thanks

Member@user_103815

Routine phlebotomy gives 80% of the PFAS clearance benefit of full therapeutic plasma exchange without the $50k annual clinic overhead.

♥ 21 Thanks

🎁

Monthly Super Giveaway Free

Win $5,000 Cash, Amazon & Starbucks eGifts on free signup.

Member@user_771937

Endothelial glycocalyx degradation precedes clinical vascular stiffness by decades. Need better non-invasive diagnostic tracking protocols.

♥ 34 Thanks

Entity and Market Metadata

Sector: Healthcare and BiotechnologyIndustry: Longevity and Rejuvenation BiotechnologyFounder: Aubrey de GreyFounder: Bryan JohnsonLeadership: Peter Attia (Key Researcher)Leadership: David Sinclair (Key Researcher)Holder: SENS Research FoundationHolder: Human Longevity Inc.Holder: Venture Capital Longevity FundsSenolyticsGene TherapyNAD+ BoostersAI-Driven DiagnosticsCryopreservation#longevity#healthspan#anti-aging#senolytics#life extension#bigerontology